Reported Q: Q1 2025 Rev YoY: N/A EPS YoY: +90.5% Move: 0.00%
PreAxia Health Care
PAXH
$0.220 0.00%
Exchange OTC Sector Healthcare Industry Medical Healthcare Information Services
Q1 2025
Published: Nov 22, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for PAXH

Reported

Report Date

Nov 22, 2024

Quarter Q1 2025

Revenue

N/A

YoY: N/A

EPS

0.00

YoY: +90.5%

Market Move

0.00%

Previous quarter: Q4 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • EPS of $0.00 increased by 90.5% from previous year
  • Net income of -4.63K
  • "" -
PAXH
Company PAXH

Executive Summary

PreAxia Health Care Payment Systems Inc (PAXH) reported QQ1 2025 with no revenue disclosed in the filing, and a net loss of $4,627, all arising from operating expenses of $4,627 (general and administrative). The company shows a minimal cash balance trajectory, a small operating cash burn of $2.40 million on an annualized scale given the quarterly basis, and a debt load of $1.72 million on a short-term basis. The balance sheet reflects a negative equity position of approximately $2.40 million against total current liabilities of about $2.40 million, signaling fragile liquidity without a material revenue base. Net cash used in operating activities was $2,396 for the quarter, offset by $2,383 in financing activities, resulting in a net cash decrease of $13 while beginning cash was $14. This suggests the business is in a pre-revenue phase relying on external funding or capital markets to sustain operations while it continues to develop and market its health care payment processing platform and related services.

Management commentary is not available in the provided transcript dataset, limiting the ability to quote strategic guidance or tactical pivots directly. Given the lack of reported revenue and the ongoing burn, the key near-term questions for investors center on whether the company can monetize its platform, secure contractual commitments with third-party administrators or insurers, and raise additional capital to support product development and go-to-market efforts. Absent explicit forward guidance, the investment thesis hinges on potential revenue traction, speed of platform deployment, and the ability to attract strategic partners that can convert platform development into sustainable cash flow.

Key Performance Indicators

Operating Income
Increasing
-4.63K
QoQ: -0.35% | YoY: 88.69%
Net Income
Increasing
-4.63K
QoQ: -0.35% | YoY: 88.69%
EPS
Increasing
0.00
QoQ: 0.00% | YoY: 90.48%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 0.00 0.00 +0.0% View
Q1 2025 0.00 0.00 +0.0% View
Q4 2024 0.00 0.00 +0.0% View
Q3 2024 0.00 0.00 +0.0% View
Q2 2024 0.00 0.00 +0.0% View